In this paper he performance of Oktal Pharma d.o.o. was analyzed and certain financial indicators were compared with the indicators of the three biggest competitors of that company, i.e. with other wholesale drug stores in the Republic of Croatia. Financial analysis provides insight into the stability and performance of a particular company. The economic effects of business events and transactions are presented in the basic financial statements. These effects are categorized into different groups known as elements of financial statements. The primary objective of basic financial statements is to provide accurate accounting information to internal and external stakeholders (such as creditors, investors, customers, government bodies and the general public) in order to communicate the financial position and operational achievements of a particular enterprise. In addition, insight into the company's financial condition can be gained by analyzing individual and synthetic financial statements. To determine the performance of Oktal Pharma d.o.o. in the period from 2016 to 2020, a horizontal and vertical analysis of certain basic financial statements and an analysis of individual and synthetic financial indicators were made, and then a comparative financial analysis was carried out in order to obtain an even clearer picture of the financial stability and performance of the selected company. The conducted analysis showed that the company Oktal Pharma d.o.o. in the observed five-year period, it was not liquid, that it was in debt, but that it effectively managed its assets and operated with a profit, as well as that it was profitable. Synthetic indicators showed that the company was in danger of financial collapse, but they should be taken with a grain of salt. Comparison of certain financial indicators of the company Oktal Pharma d.o.o. in the same period with competitors (the companies Medika d.d., Phoenix farmacija d.d. and Medical intertrade d.o.o.) showed that the company is financially stable to the same extent as its competitors and that its business is equally successful.